Urofollitropin, also known as follicle-stimulating hormone (FSH), is a
medication commonly used in reproductive medicine to stimulate the ovaries and
induce ovulation. The price of urofollitropin varies depending on the country,
region, and brand, but it can be an expensive medication.
In the United States, a vial of urofollitropin typically costs between 300
to300to500, and a full treatment cycle may require multiple vials. In the United
Kingdom, urofollitropin costs around £180 per vial. In India, the cost of
urofollitropin ranges from INR 9000 to INR 15000, while in Australia, the price
of a vial can range from AUD 80 to AUD 150.
The high cost of urofollitropin can be a burden for patients who require
the medication. In some countries, insurance may cover a portion of the cost,
while in others, the full amount must be paid out of pocket. Patients may also
choose to purchase urofollitropin from overseas pharmacies at a lower price, but
this can come with its own set of risks.
Despite the high cost, urofollitropin can be a valuable medication for
those struggling with infertility or undergoing fertility treatments. It is
important for patients to discuss all options and costs with their healthcare
provider before starting treatment with urofollitropin or any other
medication.